Anika Therapeutics (ANIK) Acquires Fidia Farmaceutici Subsidiary in $17.1M Cash and 1.98M Common Stock Transaction
Tweet Send to a Friend
Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that it has acquired Fidia Advanced Biopolymers, s.r.l. (“FAB”), a wholly-owned subsidiary of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


